Laura Joszt

Health care employment may be continuing to grow, albeit at a slower rate, but physicians offices shed jobs in June.

Fiscal uncertainty is on the minds medical practice professionals who have to deal with rapid changes to the health care profession.

Some investors are just too impatient to wait 10, 15 or 20 years to see returns. Here are 15 stocks that should pay off by July 2013.

Paying $60 million is a small price for Apple to pay for the right to sell the iPad in China, the second-largest market for Apple.

Physicians would do well to have a bit more business knowledge, and these top business schools can help.

Despite being slapped with a record-breaking fine for health care fraud, GlaxoSmithKline's stock is mostly unchanged, jumping up on Monday but correcting on Tuesday.

Orbitz is pushing Mac users to more expensive hotel options because they typically spend 30% more than PC users.

The ruling by the Supreme Court to uphold the Affordable Care Act means the country will be going through a number of changes over the next few years that will not only affect the health of Americans, but also their money.

Americans are completely split over whether the ACA ruling was right or not. Regardless, since the law was passed in 2010, Americans have been feeling more confident in the medical system

The decision by the Supreme Court to uphold the Affordable Care Act was largely surprising on Thursday and prompted responses on this landmark and controversial law from all corners.

Although the overall market is down, led by bank stocks, the health sector is looking a little better thanks to large gains from hospital stocks.

The Supreme Court has upheld the Affordable Care Act with Chief Justice Roberts voting with the left to save the law.

The global pharmaceuticals industry is looking to cash in by accessing a new market: emerging and developing countries. The majority of these companies' growth will come from this area over the next decade.

For the first time in 13 years, the U.S Food and Drug Administration (FDA) approved a new prescription weight-loss drug, lorcaserin, sending shares of Arena Pharmaceuticals soaring.

Given that a monumental, game-changing decision from the Supreme Court is right around the corner, health care stocks are sort of limbo right now.

Have we learned nothing from the recession? More than a quarter of Americans have absolutely no emergency funds in place, more than a year ago.

The Supreme Court has determined to make the country sweat it out for as long as possible, apparently, and won't announce its decision on ACA until Thursday.

While Onyx Pharmaceuticals is flying high on good news for its blood cancer drug, Celgene wasn't quite so lucky.

The rental market is looking very attractive right now, for both renters and landlords. Here are the market's popular trends.

Shares of Onyx Pharmaceuticals jumped by more than 40% on Thursday as its multiple myeloma drug gained the advisory board's unanimous approval.

With medical schools on target to increase enrollment by 30% by 2016, it's important that students accepted into schools actually enroll. Here are the top 10 schools with the highest percentage of students who enroll once they are accepted.

The Medical College Admission Test is getting a redesign for future medical school students with changes that will take effect in 2015.

Although a Gallup poll reported that Americans think quite highly of the honesty and ethics of their health care providers, other reports reveal that physicians aren't always as honest as patients think.

Over the last two years the number of hospitals using health information technology has more than doubled, according to the U.S. Department of Health and Human Services.

A little over a month after disclosing a bad trade that resulted in $2 billion in losses, JPMorgan has divested itself of the majority of its position, leading its stock price higher.

The American Medical Association voted to adopt policy that there should be taxes on sugar-sweetened beverages, just as they have for tobacco and alcohol.

The science of creating the perfect tweet may have finally been discovered and it's really not as difficult as you would think.

The biotech industry is stable for now, but it won't be able to rely on big pharma for much buyouts in the next few years.

Americans are feeling distinctly out of control when it comes to their efforts to maintain or build retirement savings.

This is the end of the road for Infinity Pharmaceuticals' cancer drug saridegib. After the company shut down two failed studies of the drug, it announced that there were no more studies planned for saridegib.